- Report
- March 2026
- 381 Pages
Global
From €5244EUR$5,850USD£4,544GBP
- Report
- March 2026
- 272 Pages
Global
From €5244EUR$5,850USD£4,544GBP
- Report
- March 2026
- 193 Pages
Global
From €5244EUR$5,850USD£4,544GBP
- Report
- March 2026
- 131 Pages
Global
From €5244EUR$5,850USD£4,544GBP
- Report
- March 2026
- 276 Pages
Global
From €5244EUR$5,850USD£4,544GBP
- Report
- March 2026
- 258 Pages
Global
From €5244EUR$5,850USD£4,544GBP
- Report
- January 2026
- 180 Pages
Global
From €4034EUR$4,500USD£3,495GBP
- Report
- January 2026
- 180 Pages
Global
From €4034EUR$4,500USD£3,495GBP
- Report
- January 2026
- 180 Pages
Global
From €4034EUR$4,500USD£3,495GBP
- Report
- January 2026
- 180 Pages
Global
From €4034EUR$4,500USD£3,495GBP
- Report
- January 2026
- 185 Pages
Global
From €4034EUR$4,500USD£3,495GBP
- Report
- January 2026
- 185 Pages
Global
From €4034EUR$4,500USD£3,495GBP
- Report
- January 2026
- 185 Pages
Global
From €4034EUR$4,500USD£3,495GBP
- Report
- January 2026
- 181 Pages
Global
From €4034EUR$4,500USD£3,495GBP
- Report
- November 2025
- 187 Pages
Global
From €4034EUR$4,500USD£3,495GBP
- Report
- August 2025
- 180 Pages
Global
From €4034EUR$4,500USD£3,495GBP
- Report
- April 2025
- 184 Pages
Global
From €4034EUR$4,500USD£3,495GBP
- Report
- May 2025
- 106 Pages
Global
From €4258EUR$4,750USD£3,689GBP
- Report
- March 2026
- 400 Pages
Global
From €4436EUR$4,949USD£3,844GBP
- Report
- March 2026
- 150 Pages
Global
From €2419EUR$2,699USD£2,096GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more